SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Pastimes : Home on the range where the buffalo roam -- Ignore unavailable to you. Want to Upgrade?

To: mishedlo who wrote (10199)2/15/2001 1:35:43 AM
From: rx4pain  Respond to of 13572
 
mishedlo-What is gonna lead us out of this...the bios?

I don't know. You'd have to be looking at companies making money from the gene mapping. I think MEDX makes money selling genetically engineered lab mice. Even companies with drugs in late stage testing can still be a year or more away from actual revenues. 7-10 years from discovery to market, thats the rule for pharmaceuticals anyway.

As for short-term trades, I guess you'd just apply TA to them, as any other stock.

I know you like that CRA secondary. All they have to do now is announce a share buyback to cover the short! LOL.
Rx



To: mishedlo who wrote (10199)2/15/2001 9:46:32 AM
From: Boplicity  Read Replies (1) | Respond to of 13572
 
I always rather buy the promise. Less defined and the larger it is perceived, the better. Think about that little. If the promise was fully know it would be priced in.

Yes, nice post.

greg


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News